Carnick & Kubik’s Teva Pharmaceuticals TEVA Stock Holding History

Carnick & Kubik’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$712K	Buy	13,304 +295	+2%	+$17.3K	0.21%	127
2015 Q4	$854K	Buy	13,009 +609	+5%	+$37.6K	0.55%	58
2015 Q3	$700K	Buy	+12,400	New	+$804K	0.49%	68
2015 Q2	–	Sell	-10,225	Closed	-$637K	–	123
2015 Q1	$637K	Buy	10,225 +75	+0.7%	+$4.36K	0.53%	71
2014 Q4	$584K	Buy	10,150 +700	+7%	+$39K	0.5%	72
2014 Q3	$508K	Buy	+9,450	New	+$501K	0.47%	78

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Carnick & Kubik's TEVA Position: Q1 2016 in Review

Carnick & Kubik increased its Teva Pharmaceuticals (TEVA) stake by 2.3% in Q1 2016, buying an estimated $17.3K and bringing the position to 13,304 shares worth $712K. The position accounts for 0.21% of the portfolio, ranked #127.

Carnick & Kubik first reported a position in TEVA in Q3 2014 and has held it in 6 quarters since. The position peaked at $854K in Q4 2015. 836 funds tracked by Wall St. Rank hold TEVA as of Q1 2016.

Carnick & Kubik held 13,304 shares of Teva Pharmaceuticals worth $712K as of Q1 2016.
Carnick & Kubik bought 295 Teva Pharmaceuticals shares in Q1 2016, an estimated $17.3K.
Teva Pharmaceuticals made up 0.21% of Carnick & Kubik's portfolio in Q1 2016, its #127 holding.
Carnick & Kubik first reported a position in Teva Pharmaceuticals in Q3 2014 and has held it in 6 quarters since.
Carnick & Kubik's Teva Pharmaceuticals position peaked at $854K in Q4 2015.
836 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2016.

Based on Carnick & Kubik's 13F filing for Q1 2016, filed 12 May 2016.